Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Methamphetamine | 8 | 2016 | 155 | 0.950 |
Why?
|
Amphetamine-Related Disorders | 7 | 2016 | 63 | 0.940 |
Why?
|
Child Psychiatry | 1 | 2020 | 3 | 0.760 |
Why?
|
Impulsive Behavior | 2 | 2017 | 44 | 0.730 |
Why?
|
Health Services Accessibility | 1 | 2020 | 531 | 0.550 |
Why?
|
Education, Medical, Graduate | 1 | 2015 | 53 | 0.540 |
Why?
|
Patient Care Team | 1 | 2015 | 44 | 0.540 |
Why?
|
Mental Health Services | 1 | 2015 | 108 | 0.490 |
Why?
|
Brain Mapping | 2 | 2015 | 108 | 0.470 |
Why?
|
Telemedicine | 1 | 2015 | 163 | 0.430 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2009 | 15 | 0.360 |
Why?
|
Central Nervous System Stimulants | 4 | 2014 | 165 | 0.330 |
Why?
|
Brain | 4 | 2016 | 1268 | 0.250 |
Why?
|
HIV Infections | 1 | 2017 | 2207 | 0.230 |
Why?
|
Hawaii | 3 | 2020 | 1878 | 0.230 |
Why?
|
Adolescent | 7 | 2020 | 5035 | 0.220 |
Why?
|
Neuropsychological Tests | 3 | 2017 | 255 | 0.210 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2016 | 155 | 0.200 |
Why?
|
Magnetic Resonance Imaging | 5 | 2016 | 468 | 0.200 |
Why?
|
Adolescent Psychiatry | 1 | 2020 | 3 | 0.190 |
Why?
|
Young Adult | 7 | 2017 | 4012 | 0.190 |
Why?
|
Humans | 17 | 2020 | 34853 | 0.180 |
Why?
|
Neural Pathways | 2 | 2016 | 120 | 0.170 |
Why?
|
Basal Ganglia | 2 | 2009 | 17 | 0.170 |
Why?
|
Mental Disorders | 2 | 2015 | 285 | 0.170 |
Why?
|
Male | 15 | 2017 | 18870 | 0.160 |
Why?
|
Primary Health Care | 1 | 2020 | 283 | 0.150 |
Why?
|
Female | 15 | 2017 | 19873 | 0.150 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2016 | 5 | 0.150 |
Why?
|
Child | 4 | 2020 | 2875 | 0.150 |
Why?
|
Tobacco Smoke Pollution | 1 | 2016 | 45 | 0.140 |
Why?
|
Developmental Disabilities | 1 | 2016 | 59 | 0.140 |
Why?
|
Neurogenesis | 1 | 2015 | 55 | 0.130 |
Why?
|
Infant, Premature | 1 | 2015 | 128 | 0.130 |
Why?
|
Adult | 8 | 2017 | 11034 | 0.130 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2016 | 18 | 0.130 |
Why?
|
Hydrocortisone | 1 | 2015 | 72 | 0.130 |
Why?
|
Cultural Competency | 1 | 2015 | 120 | 0.130 |
Why?
|
Program Development | 1 | 2015 | 225 | 0.120 |
Why?
|
Sex Characteristics | 1 | 2016 | 213 | 0.120 |
Why?
|
Saliva | 1 | 2015 | 97 | 0.120 |
Why?
|
Methylphenidate | 1 | 2014 | 51 | 0.120 |
Why?
|
Gestational Age | 1 | 2014 | 190 | 0.120 |
Why?
|
Case-Control Studies | 3 | 2016 | 1056 | 0.120 |
Why?
|
Marijuana Abuse | 1 | 2015 | 83 | 0.120 |
Why?
|
Schizophrenia | 2 | 2005 | 73 | 0.120 |
Why?
|
Child Development | 1 | 2014 | 84 | 0.120 |
Why?
|
Functional Laterality | 2 | 2009 | 75 | 0.110 |
Why?
|
Middle Aged | 3 | 2017 | 9642 | 0.100 |
Why?
|
Gyrus Cinguli | 1 | 2011 | 23 | 0.100 |
Why?
|
Cytokines | 1 | 2015 | 569 | 0.100 |
Why?
|
Choline | 1 | 2011 | 57 | 0.100 |
Why?
|
Cognition | 2 | 2011 | 373 | 0.090 |
Why?
|
Pituitary-Adrenal System | 1 | 2010 | 36 | 0.090 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2010 | 49 | 0.090 |
Why?
|
Anisotropy | 1 | 2009 | 24 | 0.090 |
Why?
|
Frontal Lobe | 1 | 2009 | 49 | 0.090 |
Why?
|
Cerebellum | 2 | 2014 | 69 | 0.090 |
Why?
|
Infant, Newborn | 3 | 2016 | 871 | 0.080 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2015 | 243 | 0.080 |
Why?
|
Hippocampus | 2 | 2014 | 546 | 0.080 |
Why?
|
Brain Diseases | 1 | 2007 | 33 | 0.080 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2015 | 164 | 0.070 |
Why?
|
Aged | 1 | 2017 | 6448 | 0.070 |
Why?
|
Sex Factors | 3 | 2016 | 859 | 0.060 |
Why?
|
Schizophrenic Psychology | 1 | 2003 | 17 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2016 | 841 | 0.060 |
Why?
|
Psychotic Disorders | 1 | 2003 | 52 | 0.050 |
Why?
|
Infant | 2 | 2015 | 1014 | 0.050 |
Why?
|
Cohort Studies | 2 | 2016 | 1422 | 0.050 |
Why?
|
Cerebral Cortex | 1 | 2003 | 274 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2003 | 233 | 0.050 |
Why?
|
Pregnancy | 2 | 2016 | 1503 | 0.040 |
Why?
|
Muscle Tonus | 1 | 2016 | 6 | 0.040 |
Why?
|
Neurologic Examination | 1 | 2016 | 31 | 0.040 |
Why?
|
Anatomy, Artistic | 1 | 2015 | 1 | 0.040 |
Why?
|
Atlases as Topic | 1 | 2015 | 3 | 0.040 |
Why?
|
Term Birth | 1 | 2015 | 9 | 0.040 |
Why?
|
Personality Inventory | 1 | 2016 | 73 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 1 | 2015 | 18 | 0.030 |
Why?
|
Probability | 1 | 2015 | 75 | 0.030 |
Why?
|
Lateral Ventricles | 1 | 2014 | 8 | 0.030 |
Why?
|
Putamen | 1 | 2014 | 15 | 0.030 |
Why?
|
Caudate Nucleus | 1 | 2014 | 19 | 0.030 |
Why?
|
Thalamus | 1 | 2014 | 29 | 0.030 |
Why?
|
Globus Pallidus | 1 | 2014 | 16 | 0.030 |
Why?
|
Brain Stem | 1 | 2014 | 46 | 0.030 |
Why?
|
Organ Size | 1 | 2014 | 148 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2014 | 57 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2005 | 145 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2014 | 269 | 0.030 |
Why?
|
Amygdala | 1 | 2014 | 110 | 0.030 |
Why?
|
Antipsychotic Agents | 2 | 2005 | 68 | 0.030 |
Why?
|
Time Factors | 2 | 2010 | 1681 | 0.030 |
Why?
|
Los Angeles | 1 | 2014 | 368 | 0.030 |
Why?
|
Prospective Studies | 1 | 2016 | 1353 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2014 | 964 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2014 | 1349 | 0.020 |
Why?
|
Executive Function | 1 | 2010 | 47 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2010 | 126 | 0.020 |
Why?
|
Memory | 1 | 2010 | 165 | 0.020 |
Why?
|
Attention | 1 | 2010 | 147 | 0.020 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2008 | 18 | 0.020 |
Why?
|
Age Factors | 1 | 2011 | 1007 | 0.020 |
Why?
|
Demography | 1 | 2008 | 167 | 0.020 |
Why?
|
Pilot Projects | 1 | 2008 | 628 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2007 | 281 | 0.020 |
Why?
|
Glucose | 1 | 2007 | 217 | 0.020 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2005 | 94 | 0.020 |
Why?
|
Cerebellar Nuclei | 1 | 2002 | 3 | 0.010 |
Why?
|
Child, Preschool | 1 | 2007 | 1318 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2002 | 67 | 0.010 |
Why?
|
Software | 1 | 2002 | 204 | 0.010 |
Why?
|
Prognosis | 1 | 2003 | 707 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2002 | 901 | 0.010 |
Why?
|